| PEB0088 | The feasibility and challenges of diagnosing and treating acute HIV infection in a resource limited high HIV incidence setting in Eswatini | E-poster | B1 |
| PEB0089 | Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in acute and early human immunodeficiency virus (HIV)'1 infection: A DIAMOND subgroup analysis | E-poster | B1 |
| OAB0502 | Efficacy and safety outcomes (HIV subgroup analysis) in the Nix-TB Trial - bedaquiline, pretomanid and linezolid for treatment of extensively resistant, intolerant or non-responsive pulmonary multidrug-resistant tuberculosis | Oral abstract session with live Q&A | B10 |
| OAB0503 | Prevalence and incidence of tuberculosis infection and disease among household contacts exposed to rifampin-resistant/multidrug resistant tuberculosis (RR/MDR-TB) | Oral abstract session with live Q&A | B10 |
| OAB0504 | Assessment of the tuberculosis clinical cascade among children living with HIV on antiretroviral therapy, 16 Sub-Saharan PEPFAR-supported programs, October 1, 2018 to March 31, 2019 | Oral abstract session with live Q&A | B10 |
| OAB0505 | Risk factors for hepatotoxicity in HIV-infected women receiving isoniazid preventive therapy in pregnancy and postpartum | Oral abstract session with live Q&A | B10 |
| OAB0506 | Validation of a laboratory-based reference test for TB-LAM and FLOW-TB, a novel point-of-care TB diagnostic assay, in a high-HIV-prevalence clinical cohort from KwaZulu-Natal, South Africa | Oral abstract session with live Q&A | B10 |
| OAB0507 | TB contact investigations as an active HIV case finding strategy in Mozambique: Lessons for high TB and HIV syndemic countries | Oral abstract session with live Q&A | B10 |
| PEB0128 | The tuberculosis care cascade in Zambia: Identifying the gaps in order to improve outcomes | E-poster | B10 |
| PEB0129 | Enhancing TB diagnosis in HIV+ patients in Kenya: Preliminary results of IDEA-TB study in a cohort from DREAM program | E-poster | B10 |